clindamycin

(redirected from Evoclin)
Also found in: Medical.
Related to Evoclin: Cleocin T

clin·da·my·cin

 (klĭn′də-mī′sĭn)
n.
A semisynthetic antibiotic, C18H33ClN2O5S, derived from lincomycin and active against gram-positive bacteria.

[Alteration and blend of chloro- and lincomycin (with d perhaps from deoxy-).]

clindamycin

(ˌklɪndəˈmaɪsɪn)
n
(Medicine) an antibiotic used to treat bacterial infections
Translations

clindamycin

n clindamicina
References in periodicals archive ?
The GlaxoSmithKline and Stiefel products include Evoclin Foam, Extina Foam, Luxiq Foam, Olux Foam, Olux-E Foam, Vusion Ointment, Zovirax Capsules, Zovirax Tablets and Zovirax Suspension.
Evoclin is unique because of its proprietary VersaFoam vehicle, he said.
The products from GSK and Stiefel, a GSK company, which will be marketed through Renaissance's branded division Prestium Pharma, include Evoclin (clindamycin phosphate) Foam 1%; Extina (ketoconazole) Foam 2%; Luxiq (betamethasone valerate) Foam 0.
have launched a generic version of Evoclin foam 1% (clindamycin phosphate foam 1%).
The Food and Drug Administration approved Evoclin Foam, 1% for topical treatment of ache vulgaris in patients 12 years and older.
The FDA approved Evoclin (clindamycin) Foam, 1% for topical treatment of acne vulgaris in patients 12 years and older.